Blood-feeding systems for hematophagous arthropods, as well as methods of fabricating and using the same, are provided. The blood-feeding systems can be fabricated on site (e.g., in a lab) by using a three-dimensional (3D) printer (e.g., a direct drive 3D printer such as a direct drive fused deposition modeling (FDM)-type 3D printer) and regular lab tools. The blood-feeding systems can utilize a syringe filling system that allows leftover blood to be recovered after use, or added or changed while the feeder is in use.

Blood-feeding systems for hematophagous arthropods, as well as methods of fabricating and using the same, are provided. The blood-feeding systems can be fabricated on site (e.g., in a lab) by using a three-dimensional (3D) printer (e.g., a direct drive 3D printer such as a direct drive fused deposition modeling (FDM)-type 3D printer) and regular lab tools. The blood-feeding systems can utilize a syringe filling system that allows leftover blood to be recovered after use, or added or changed while the feeder is in use.

A vaccine composition comprising a virus antigen wherein the composition comprises less than 5% serum, wherein the virus antigen is a whole virus or derived from a whole virus, the vaccine composition reduces, prevents or avoids cross-stitch spinal deformity in the treated animal. Said vaccine composition for use in a method of treating a disease caused by the intracellular pathogen in an animal and reducing, preventing or avoiding cross-stitch spinal deformity in the treated animal. In cross-stitch vertebra the intervertebral space is completely collapsed. A vaccine composition for use as defined above wherein the animal is a fish. In an embodiment the pathogen is salmon alpha virus (SAV).

A vaccine composition comprising a virus antigen wherein the composition comprises less than 5% serum, wherein the virus antigen is a whole virus or derived from a whole virus, the vaccine composition reduces, prevents or avoids cross-stitch spinal deformity in the treated animal. Said vaccine composition for use in a method of treating a disease caused by the intracellular pathogen in an animal and reducing, preventing or avoiding cross-stitch spinal deformity in the treated animal. In cross-stitch vertebra the intervertebral space is completely collapsed. A vaccine composition for use as defined above wherein the animal is a fish. In an embodiment the pathogen is salmon alpha virus (SAV).

A method of making a food product can include forming an emulsion containing a meat and a firming agent that is one or more of plasma, whole egg powder, guar gum, pea fiber, pea protein, carboxymethyl cellulose (CMC) or a modified cereal starch; directing the emulsion through a die to form a meat analog; cooking the meat analog with steam; and cutting the meat analog into thin flakes. The method can include cooling the meat analog before the cutting. The method can include mixing the thin flakes of the meat analog with jelly or gravy to form a blended food composition in which a ratio of the flakes to the jelly or gravy is about 30:70 to about 70:30.

A method of making a food product can include forming an emulsion containing a meat and a firming agent that is one or more of plasma, whole egg powder, guar gum, pea fiber, pea protein, carboxymethyl cellulose (CMC) or a modified cereal starch; directing the emulsion through a die to form a meat analog; cooking the meat analog with steam; and cutting the meat analog into thin flakes. The method can include cooling the meat analog before the cutting. The method can include mixing the thin flakes of the meat analog with jelly or gravy to form a blended food composition in which a ratio of the flakes to the jelly or gravy is about 30:70 to about 70:30.

Provided herein are methods and compositions related to plant based meat substitutes which have properties similar to meat.

Provided herein are methods and compositions related to plant based meat substitutes which have properties similar to meat.

A marine peptide product derived from by-products of fish processing is provided. In particular, an animal food product, such as a biscuit, comprising marine peptides is provided. This product has health benefits including antihypertension activities.

A marine peptide product derived from by-products of fish processing is provided. In particular, an animal food product, such as a biscuit, comprising marine peptides is provided. This product has health benefits including antihypertension activities.